129 related articles for article (PubMed ID: 38124355)
21. Black ginger extract and its active compound, 5,7-dimethoxyflavone, increase intestinal drug absorption via efflux drug transporter inhibitions.
Boonnop R; Meetam P; Siangjong L; Tuchinda P; Thongphasuk P; Soodvilai S; Soodvilai S
Drug Metab Pharmacokinet; 2023 Jun; 50():100500. PubMed ID: 36948091
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in rats.
Katagiri Y; Kawaguchi H; Umemura K; Tadano J; Miyawaki I; Takano M
Drug Metab Pharmacokinet; 2022 Feb; 42():100430. PubMed ID: 34896751
[TBL] [Abstract][Full Text] [Related]
23. Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model.
Kosugi Y; Mizuno K; Santos C; Sato S; Hosea N; Zientek M
AAPS J; 2021 May; 23(4):72. PubMed ID: 34008121
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
25. TGF-β1 elevates P-gp and BCRP in hepatocellular carcinoma through HOTAIR/miR-145 axis.
Kong J; Qiu Y; Li Y; Zhang H; Wang W
Biopharm Drug Dispos; 2019 Feb; 40(2):70-80. PubMed ID: 30698830
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo.
Zhang Y; Shipkova PA; Warrack BM; Nelson DM; Wang L; Huo R; Chen J; Panfen E; Chen XQ; Fancher RM; Ruan Q; Christopher LJ; Xue Y; Sinz M; Shen H
Drug Metab Dispos; 2023 Jul; 51(7):851-861. PubMed ID: 37055191
[TBL] [Abstract][Full Text] [Related]
27. Effect of oxygen on multidrug resistance in term human placenta.
Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
[TBL] [Abstract][Full Text] [Related]
28. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
29. Developing an In Vitro to In Vivo Extrapolation (IVIVE) Model to Predict Human Milk-to-Plasma Drug Concentration Ratios.
Yang H; Xue I; Gu Q; Zou P; Zhang T; Lu Y; Fisher J; Tran D
Mol Pharm; 2022 Jul; 19(7):2506-2517. PubMed ID: 35675046
[TBL] [Abstract][Full Text] [Related]
30. Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood-Brain Barrier.
Shan Y; Cen Y; Zhang Y; Tan R; Zhao J; Nie Z; Zhang J; Yu S
Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):279-289. PubMed ID: 35112329
[TBL] [Abstract][Full Text] [Related]
31. Practical Application of Rodent Transporter Knockout Models to Assess Brain Penetration in Drug Discovery.
Eneberg E; Jones CR; Jensen T; Langthaler K; Bundgaard C
Drug Metab Bioanal Lett; 2022; 15(1):12-21. PubMed ID: 35196975
[TBL] [Abstract][Full Text] [Related]
32. Using the lentiviral vector system to stably express chicken P-gp and BCRP in MDCK cells for screening the substrates and studying the interplay of both transporters.
Zhang Y; Huang J; Liu Y; Guo T; Wang L
Arch Toxicol; 2018 Jun; 92(6):2027-2042. PubMed ID: 29725709
[TBL] [Abstract][Full Text] [Related]
33. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
[TBL] [Abstract][Full Text] [Related]
34. Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells.
Lye P; Bloise E; Imperio GE; Chitayat D; Matthews SG
Cells; 2022 Jul; 11(14):. PubMed ID: 35883702
[TBL] [Abstract][Full Text] [Related]
35. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
36. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein.
Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J
J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825
[TBL] [Abstract][Full Text] [Related]
37. Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats.
Mairinger S; Hernández-Lozano I; Filip T; Sauberer M; Löbsch M; Stanek J; Wanek T; Sake JA; Pekar T; Ehrhardt C; Langer O
J Control Release; 2022 Sep; 349():109-117. PubMed ID: 35798092
[TBL] [Abstract][Full Text] [Related]
38. Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies.
Kozłowska-Rup D; Czekaj P; Plewka D; Sikora J
Ginekol Pol; 2014 Jun; 85(6):410-9. PubMed ID: 25029804
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages.
Mathias AA; Hitti J; Unadkat JD
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R963-9. PubMed ID: 15961534
[TBL] [Abstract][Full Text] [Related]
40. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]